Search results
Order by most recent / most popular / relevance
Results: 1-10 of 14
Allegations against Johnson & Johnson and Novartis of deliberately delaying market entry of generics
- Nabarro LLP
- -
- European Union
- -
- November 10 2011
Maintaining its vigilance towards the pharmaceutical industry, the Commission has opened an “own initiative” investigation into contractual arrangements between Johnson & Johnson and Novartis
Problematic pharma patent settlement cases decreasing
- Nabarro LLP
- -
- European Union
- -
- July 27 2011
The number of patent settlement agreements which raise competition issues have declined over the past year
Commission launches new review of pharma patent settlements
- Nabarro LLP
- -
- European Union
- -
- January 18 2011
For the second time since it carried out its competition review of the pharmaceutical sector, the European Commission is monitoring patent settlement agreements
Commission fines a French pharmaceutical association 5m
- Nabarro LLP
- -
- European Union, France
- -
- January 5 2011
The European Commission fined the Ordre National des Pharmaciens (ONP) 5m for imposing minimum prices on the French market for clinical laboratory tests and hindering the development of laboratories
Commission asks ECJ to fine Greece for failure to comply with its judgment on medical equipment
- Nabarro LLP
- -
- European Union, Greece
- -
- November 29 2010
On 19 March 2009, the European Court of Justice (ECJ) ruled that Greece had breached EU law by rejecting offers from suppliers of medical equipment bearing the 'CE' mark
General Court dismisses appeal against dawn raid of French pharmacy associations
- Nabarro LLP
- -
- European Union, France
- -
- November 16 2010
The General Court has dismissed an appeal by two French Pharmacy associations (the 'CONP' and the 'CCG') against a decision by the European Commission ordering them to submit to an unannounced competition inspection
French pharmaceutical group accused of providing misleading information during the ‘phama inquiry’
- Nabarro LLP
- -
- European Union
- -
- August 9 2010
The European Commission claims it has evidence that a French pharmaceutical group, Servier, provided misleading and incorrect information in the context of the pharmaceutical sector competition inquiry in 2008
Astrazeneca patent misuse case largely upheld
- Nabarro LLP
- -
- European Union
- -
- July 16 2010
On 1 July 2010, the General Court upheld the majority of the Commission's 2005 decision to fine pharmaceutical company, AstraZeneca, for abuses of a dominant position
Rules on pharmacy opening times not anti-competitive advises Advocate-General
- Nabarro LLP
- -
- European Union
- -
- March 22 2010
Advocate General Jaaskinen's Op supports Member States' right to maintain regional laws restricting pharmacy opening hours
Patent settlement agreements come under Commission scrutiny
- Nabarro LLP
- -
- European Union
- -
- January 28 2010
Hot on the heels of the pharmaceutical sector inquiry in 2009 and the formal proceedings opened against Lundbeck, the European Commission revealed that it sent requests to a number of large pharmaceutical companies for copies of recent patent settlement agreements
Current Search
- Jurisdiction - European Union
- Author - Brian Sher
- Workarea - Healthcare